Background: The impact of side effects (SEs) of second-generation antipsychotics (SGAs) on patients’ physical and emotional functioning and overall quality of life (QoL) is insufficiently...
Background: The efficacy and safety of adjunctive brexpiprazole, a serotonin–dopamine activity modulator, has been demonstrated in clinical studies in adults with MDD and inadequate respo...
Introduction: The efficacy and safety of brexpiprazole in the treatment of schizophrenia have been demonstrated in short- and long-term studies. This post-hoc analysis assessed the propor...
Background: Second-generation antipsychotics (SGAs) are associated with well-known side effects (SEs). We aimed to gain a patients’ perspective on how specific SEs impact daily functionin...
Background: We aimed to determine the effects of adjunctive brexpiprazole on sexual functioning in adults with major depressive disorder (MDD), according to antidepressant treatment (ADT)...